Physician profile
Megan E Johnson
NPI 1588336283
$1,357.13
in general payments reported to CMS, 2019-2025
12 companies · $512 in 2025
The $512 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.73 · 2022: $28.81 · 2023: $312 · 2024: $483 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,307.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $394.12 | 2023-2025 | Sublocade |
| Braeburn INC. | $337.83 | 2023-2025 | Brixadi |
| Uswm, LLC | $163.37 | 2023-2024 | Lucemyra, Zimhi |
| Alkermes, INC. | $127.16 | 2023-2025 | Aristada, Vivitrol, Vivitrol |
| Otsuka America Pharmaceutical, INC. | $111.55 | 2024-2025 | Rexulti |
| Abbvie INC. | $99.59 | 2024-2025 | |
| Orexo US, INC. | $36.45 | 2024-2025 | Zubsolv |
| Seagen INC. | $20.73 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $19.92 | 2025 | Cobenfy |
| Corium, LLC | $17.60 | 2023 | Azstarys |
| Merck Sharp & Dohme LLC | $14.81 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $14.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.